Dr. Chan Kyo Kim

Department of Radiology, Samsung Medical Center

Sungkyunkwan University School of Medicine, South Korea

Associate Professor

E-mail: [email protected]

Qualifications

2012-2013 Visiting Scholar, Molecular Imaging LAB, USA

2006-2009 Ph.D., Kangwon National University Medical School, South Korea

2005-2006 M.Sc., Chonnam National University Medical School, South Korea

1992-1996 M.D. Chosun University, Gwangju, South Korea

1990-1991 Diploma (pre-medical), Chosun University, South Korea

Publications (Selected)

1. Kim, M. J., Park, J. J., Kang, K. A., Park, S. Y., & Kim, C. K. (2024). Utility of prostate health index density for biopsy strategy in biopsy‐naïve patients with PI‐RADS v2. 1 category 3 lesions. Journal of Magnetic Resonance Imaging, 60(4), 1628-1636.
2. Na, I., Noh, J. J., Kim, C. K., Lee, J. W., & Park, H. (2024). Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI. Frontiers in Oncology, 14, 1341228.
3. Kim, C. K., Kang, K. A., Oh, Y. L., & Park, S. Y. (2023). Role of computed tomography in predicting adrenal adenomas with cortisol hypersecretion. The British journal of radiology, 96(1149), 20221032.
4. Kim, H., Kang, S. W., Kim, J. H., Nagar, H., Sabuncu, M., Margolis, D. J., & Kim, C. K. (2023). The role of AI in prostate MRI quality and interpretation: Opportunities and challenges. European journal of radiology, 165, 110887.
5. Park, Y. W., Kang, K. A., Kim, C. K., & Park, S. Y. (2023). Prostate imaging-reporting and data system version 2 has improved biopsy tumor grade accuracy: a single, tertiary institutional experience. Abdominal Radiology, 48(7), 2370-2378.
6. Lee, H. W., Kim, E., Na, I., Kim, C. K., Seo, S. I., & Park, H. (2023). Novel multiparametric magnetic resonance imaging-based deep learning and clinical parameter integration for the prediction of long-term biochemical recurrence-free survival in prostate cancer after radical prostatectomy. Cancers, 15(13), 3416.
7. Kim, M. J., Kang, K. A., Kim, C. K., & Park, S. Y. (2023). Inter-method agreement between wash-in and wash-out computed tomography for characterizing hyperattenuating adrenal lesions as adenomas or non-adenomas. European Radiology, 33(3), 2218-2226.
8. Jeon, S. S., Kim, C. K., Park, S. Y., Chung, J. H., Kang, M., Sung, H. H., & Jeong, B. C. (2023). The utility of two-dimensional shear wave elastography for predicting prostate cancer: a preliminary study. Ultrasonography, 42(3), 400.
9. Kim, C. K. (2023). Prostate Imaging Reporting and Data System (PI-RADS) v 2.1: Overview and Critical Points. Journal of the Korean Society of Radiology, 84(1), 75-91.
10. Barrett, T., Ghafoor, S., Gupta, R. T., Kim, C. K., Muglia, V. F., Macura, K. J., & Purysko, A. S. (2022). Prostate MRI qualification: AJR expert panel narrative review. American Journal of Roentgenology, 219(5), 691-702.
11. Park, J. J., & Kim, C. K. (2022). Paradigm shift in prostate cancer diagnosis: pre-biopsy prostate magnetic resonance imaging and targeted biopsy. Korean Journal of Radiology, 23(6), 625.
12. Cho, H. H., Kim, C. K., & Park, H. (2022). Overview of radiomics in prostate imaging and future directions. The British journal of radiology, 95(1131), 20210539.
13. Yang, E., Kim, C. K., Guan, Y., Koo, B. B., & Kim, J. H. (2022). 3D multi-scale residual fully convolutional neural network for segmentation of extremely large-sized kidney tumor. Computer Methods and Programs in Biomedicine, 215, 106616.
14. Kim, Y., Park, J. J., & Kim, C. K. (2022). Blood oxygenation level-dependent MRI at 3T for differentiating prostate cancer from benign tissue: a preliminary experience. The British Journal of Radiology, 95(1131), 20210461.
15. Kim, H., Kim, R., Hong, J., Kwon, G. Y., Kim, C. K., Park, W., ... & Park, S. H. (2022). A prospective phase II trial of neoadjuvant nivolumab plus gemcitabine/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of bladder.
16. Sung, H. H., Kim, H., Kim, R., Kim, C. K., Kwon, G. Y., Park, W., ... & Park, S. H. (2022). Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder. Investigative and Clinical Urology, 63(2), 168.

Profile Details

WoS ResearcherID: H-6927-2019

https://orcid.org/0000-0003-0482-1140

https://professor.skku.edu/researcher_eng/professorList.do?mode=view&perId=LZStrNQYQ5gjApmAMAyB1ASgVngawBYE0AiAXgBwAsGAbAO4C81QA%20&categoryId=U&jojikCode1=3146

https://scholar.google.co.kr/citations?user=ggjf5MoAAAAJ&hl=ko

https://www.researchgate.net/profile/Chan-Kyo-Kim-3